Leaflet BRIVAL 125mg tablets

Product code:
W12651002
Quantity:
7
Indicated for:
herpes zoster
Route of administration:
oral
Substance:
brivudine (antiviral)
ATC
J05AB15 — Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Precautions:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Brivudine is an antiviral medication used for the treatment of varicella-zoster virus (VZV) infections, particularly in patients with shingles. It works by inhibiting viral replication, reducing the severity and duration of symptoms.

The medication is taken orally, usually once daily, as directed by a doctor. Treatment should be started as soon as possible after symptom onset to be effective.

Common side effects include nausea, headache, and fatigue. In rare cases, allergic reactions or liver function impairment may occur, requiring close monitoring of patients.

Brivudine is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about BRIVAL 125mg

Substance:
brivudine
Date of latest medicines list:
01-06-2026
Product code:
W12651002
Concentration:
125mg
Pharmaceutical form:
tablets
Quantity:
7
Product type:
Original
Price:
247.92 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BERLIN CHEMIE AG MENARINI GROUP - GERMANIA
Holder:
BERLIN CHEMIE AG MENARINI GROUP - GERMANIA
Number:
900/2008/01
Shelf life:
3 years

Compensation lists for BRIVAL 125mg Berlin Chemie

B - Sublist B with 50% discount from the reference price

Price
247.92 RON
Copayment
123.96 RON
Patient
123.96 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price
247.92 RON
Copayment
247.92 RON
Patient
0.00 RON